LATEST

• BUSINESS 25 Japan Drug Makers’ Total Operating Profit Tops 2 Trillion Yen for 1st Time: Tally
  May 20, 2025

• REGULATORY LDP Project Team Eyes Coverage Discussions for Drug Use in Pre-Symptomatic Stage
  May 20, 2025

• REGULATORY New Stelara Biosimilars Earn May Listing, Eylea Follow-On Takes Pass Again
  May 20, 2025

• REGULATORY Japan Approves Moderna RSV Vaccine, GSK’s ADC, and More
  May 20, 2025

• BUSINESS Chugai’s PNH Drug PiaSky Approved in Taiwan
  May 20, 2025

• COMMENTARY Impact of US Drug Policy: President Trump Shaking the World of Pharma
  May 19, 2025

• BUSINESS Japan’s Big 4 Wholesalers Log Operating Margin of 1.24%, All Break 1% Mark: Tally
  May 19, 2025

• ORGANIZATION At JPA’s Behest, FPMAJ Asks Members to Align Packaging with Approved Dosages
  May 19, 2025

• BUSINESS Sawai Wins Lawsuit over CML Use in Sprycel Generic
  May 19, 2025

• BUSINESS Boehringer Ingelheim, Kanagawa Join Hands in Disease Prevention
  May 19, 2025

• BUSINESS AstraZeneca, Nara City Form Partnership in NCDs
  May 19, 2025

• BUSINESS Seikagaku Eyes FDA Re-Filing of Herniated Disk Drug within 1 Year
  May 19, 2025

• ORGANIZATION PhRMA Raps Japan’s Drug Price Controls as Non-Tariff Trade Barriers, Urges US Govt Action
  May 19, 2025

• REGULATORY Ex-Lawmakers’ Club Proposes CEA Overhaul, GDP-Linked Drug Spending
  May 16, 2025

• BUSINESS Eisai Aims to Turn Leqembi to Black in FY2026 with EU Approval as Tailwind: CEO
  May 16, 2025

• REGULATORY Ex-PM Kishida Stresses Need to Bolster Innovation in Japan: Tokyo Speech
  May 16, 2025

• REGULATORY Biktarvy Gets Label Update to Add Eligible Patients
  May 16, 2025

• REGULATORY Regional Formulary Push Pops Up from Ishin at 3-Party Talks
  May 16, 2025

• BUSINESS Quviviq Retains Top Slot in Rep Calls for GPs: Intage March Data
  May 16, 2025

• BUSINESS ASKA Filed Switched OTC of Emergency Contraceptive Last June
  May 16, 2025

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »